A distinct pattern of cancer mutations in FGFR1-4 can reflect differences in cancer types and their etiology, with FGFR3 mutations being most prevalent in a single cancer type (i.e bladder cancer) [7–9]. This evidence concerns the gene FGFR3 and urinary bladder carcinoma.